Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality
- PMID: 28663234
- PMCID: PMC5657468
- DOI: 10.1161/CIRCULATIONAHA.116.024041
Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality
Abstract
Background: Pericarditis may be a serious complication of malignancy. Its significance as a first symptom of occult cancer and as a prognostic factor for cancer survival is unknown.
Methods: Using Danish medical databases, we conducted a nationwide cohort study of all patients with a first-time diagnosis of pericarditis during 1994 to 2013. We excluded patients with previous cancer and followed up the remaining patients for subsequent cancer diagnosis until November 30, 2013. We calculated risks and standardized incidence ratios of cancer for patients with pericarditis compared with the general population. We assessed whether pericarditis predicts cancer survival by the Kaplan-Meier method and Cox regression using a matched comparison cohort of cancer patients without pericarditis.
Results: Among 13 759 patients with acute pericarditis, 1550 subsequently were diagnosed with cancer during follow-up. The overall cancer standardized incidence ratio was 1.5 (95% confidence interval [CI], 1.4-1.5), driven predominantly by increased rates of lung, kidney, and bladder cancer, lymphoma, leukemia, and unspecified metastatic cancer. The <3-month cancer risk among patients with pericarditis was 2.7%, and the standardized incidence ratio was 12.4 (95% CI, 11.2-13.7). The 3- to <12-month standardized incidence ratio of cancer was 1.5 (95% CI, 1.2-1.7), subsequently decreasing to 1.1 (95% CI, 1.0-1.2). Three-month survival after the cancer diagnosis was 80% and 86% among those with and without pericarditis, respectively, and the hazard ratio was 1.5 (95% CI, 1.3-1.8). One-year survival was 65% and 70%, respectively, corresponding to a 3- to <12-month hazard ratio of 1.3 (95% CI, 1.1-1.5).
Conclusions: Pericarditis may be a marker of occult cancer and augurs increased mortality after a cancer diagnosis.
Keywords: epidemiology; neoplasms; pericardial effusion; pericarditis.
© 2017 American Heart Association, Inc.
Figures
Comment in
-
Letter by Jin-shan and Xue-bin Regarding Article, "Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality".Circulation. 2018 May 8;137(19):2096. doi: 10.1161/CIRCULATIONAHA.117.032389. Circulation. 2018. PMID: 29735602 No abstract available.
-
Response by Søgaard et al to Letter Regarding Article, "Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality".Circulation. 2018 May 8;137(19):2097-2098. doi: 10.1161/CIRCULATIONAHA.117.032516. Circulation. 2018. PMID: 29735603 Free PMC article. No abstract available.
Similar articles
-
Risk and Prognosis of Cancer After Lower Limb Arterial Thrombosis.Circulation. 2018 Aug 14;138(7):669-677. doi: 10.1161/CIRCULATIONAHA.117.032617. Circulation. 2018. PMID: 29540440
-
Risk and prognosis of cancer in patients with nephrotic syndrome.Am J Med. 2014 Sep;127(9):871-7.e1. doi: 10.1016/j.amjmed.2014.05.002. Epub 2014 May 13. Am J Med. 2014. PMID: 24838191
-
Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis.J Am Coll Cardiol. 2020 Dec 1;76(22):2623-2631. doi: 10.1016/j.jacc.2020.09.607. J Am Coll Cardiol. 2020. PMID: 33243382
-
Prognostic factors in soft tissue sarcoma.Dan Med J. 2014 Nov;61(11):B4957. Dan Med J. 2014. PMID: 25370967 Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
The Association of Minimally Invasive Surgical Approaches and Mortality in Patients with Malignant Pleuropericarditis-A 10 Year Retrospective Observational Study.Medicina (Kaunas). 2022 May 27;58(6):718. doi: 10.3390/medicina58060718. Medicina (Kaunas). 2022. PMID: 35743981 Free PMC article.
-
Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: a case report.J Med Case Rep. 2021 Oct 28;15(1):543. doi: 10.1186/s13256-021-03085-w. J Med Case Rep. 2021. PMID: 34711280 Free PMC article.
-
Pericardial Disease in Cancer Patients.Curr Treat Options Cardiovasc Med. 2018 Jun 23;20(7):60. doi: 10.1007/s11936-018-0654-7. Curr Treat Options Cardiovasc Med. 2018. PMID: 29936603 Free PMC article. Review.
-
Diversity in Acute Autoimmune Pericarditis: Nationwide Analysis of In-Hospital Outcomes and Recurrence.JACC Asia. 2024 Aug 27;4(10):721-731. doi: 10.1016/j.jacasi.2024.06.008. eCollection 2024 Oct. JACC Asia. 2024. PMID: 39553903 Free PMC article.
-
Incidence of malignant pericardial effusion in pericardiocentesis patients and post-procedure care: an oncology center pilot study.Am J Transl Res. 2023 May 15;15(5):3355-3364. eCollection 2023. Am J Transl Res. 2023. PMID: 37303650 Free PMC article.
References
-
- Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the european society of cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2015;36:2921–2964. - PMC - PubMed
-
- Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D, Ghisio A, Pomari F, Belli R, Trinchero R. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008;94:498–501. - PubMed
-
- Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113:1622–1632. - PubMed
-
- Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, Pomari F, Coda L, Belli R, Trinchero R. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115:2739–2744. - PubMed
-
- Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015;101:1159–1168. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical